Subsequently, seven common genes, including FOSL1, S100A9, CXCL12, ID2, PRS6KA3, AREG, and DUSP6, have been used as the target biomarkers for cancer diagnosis and therapy. This evidence concerns the gene FOSL1 and cancer.